Methods for redirecting T cells to treat HIV infection

摘要

The present invention relates to compositions and methods for the treatment of HIV-infected mammals using CD4 membrane-bound chimeric receptors or HIV-specific scFv CAR. One aspect includes modified T cells, and pharmaceutical compositions comprising modified cells for adoptive cell therapy, and treatment of diseases or conditions associated with HIV infection.